Explore how targeted therapies and immunotherapies transform oncology, highlighting novel antibody treatments and their impact on patient care and outcomes.
Mike Hennessy Jr, Chairman and CEO
Advertisement
Articles by Mike Hennessy Jr, Chairman and CEO
Pharmacies enhance public health by providing essential back-to-school vaccinations and addressing vaccine hesitancy, ensuring community protection this fall.
Pharmacy deserts challenge access to essential medications, but innovative solutions like telepharmacy and mobile units empower pharmacists to bridge the gap.
The treatment landscape for multiple myeloma continues to evolve.
The authors of these peer -reviewed papers collectively emphasize the evolving landscape of oncology treatment.
MJH Life Sciences is celebrating its 25th anniversary.
Advertisement
Latest Updated Articles
Mental Health Issues Affect Pharmacists as Well as PatientsPublished: July 1st 2023 | Updated:
Significant Opportunities Are Ahead to Improve Health Equity, Provide Patient-Centered Oncology Treatment, CarePublished: December 1st 2022 | Updated:
Insulin Rationing Highlights Health Care DisparitiesPublished: December 1st 2022 | Updated:
Pharmacists Step Up During CrisesPublished: February 9th 2025 | Updated:
Get Ready: Here Comes Flu SeasonPublished: September 1st 2022 | Updated:
Updated Cannabis Quality Standards, Regulation Helps Establish Its Role as MedicinePublished: July 1st 2023 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
GLP-1 Receptor Agonists Show Promise Across Alcohol, Opioid, and Tobacco Use Disorders
2
Young Women With Symptomatic Long COVID At Higher Risk of POTS
3
OpEd: The Drug Enforcement Administration Needs a Chief Pharmacy Officer. Here’s Why
4
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
5
